Researchers

Results 121-140 of 324
Issue DateTitleAuthor(s)TypeМp-cat.
2020Potential for cancer treatment: natural products from the BalkansDinić, Jelena  ; Novaković, Miroslav  ; Pešić, Milica  Book parts
13documentMNO za hemiju (20.08.2024.)
M13
2020Plectranthus mutabilis Codd as a source of Anti-MDR DiterpenoidsNtungwea, E.N.; Isca, V.; Tavares, J.; Vágvölgyi, M.; Pešić, Milica S.  ; Spengler, G.; Hunyadi, A.; Rijo, P.Conference Paper
Mp. category will be shown later
2020New pyrazolo[3,4-d]pyrimidine derivatives reverse multidrug resistance in cancer cells by inhibiting P-glycoprotein activityPodolski Renić, Ana M.  ; Dinić, Jelena B.  ; Stanković, Tijana T. ; Dragoj, Miodrag D.  ; Jovanović, Mirna  ; Jovanović Stojanov, Sofija  ; Pešić, Milica S.  Conference Paper
Mp. category will be shown later
2020Grape (Vitis vinifera L.): health benefits and effects of growing conditions on quality parametersTopalović, Ana; Knežević, Mirko; Bajagić, Balša; Ivanović, Ljubica; Milašević, Ivana; Đurović, Dijana; Mugoša, Boban; Podolski-Renić, Ana  ; Pešić, Milica  Book parts
Mp. category will be shown later
2020Molecular Docking Studies of Royleanone Diterpenoids from Plectranthus spp. as P-Glycoprotein InhibitorsIsca, Vera M. S.; Ferreira, Ricardo J.; Garcia, Catarina; Monteiro, Carlos M.; Dinić, Jelena  ; Holmstedt, Suvi; André, Vânia; Pešić, Milica  ; Dos Santos, Daniel J. V. A.; Candeias, Nuno R.;
Afonso, Carlos A. M.; Rijo, Patrícia;
Article
21aM21a
2020Biomedicine: biodiversity’s panacea? Context of commodificationJohnson, Mari-Vaughn V.; Shrestha, Uttam Babu; Neergheen, Vidushi S.; Kagansky, Alexander; Pešić, Milica  ; Malone, John H.Book parts
Mp. category will be shown later
2020Insight into P-glycoprotein activity of royleanones from Plectranthus sppVera M. S. Isca; Epole Ntungwe; Eva Domínguez-Martín; Jaime A. S. Coelho; Ricardo J. Ferreira; Dinić, Jelena B.  ; Pešić, Milica S.  ; Daniel J. V. A. dos Santos; Nuno R. Candeias; Carlos A. M. Afonso;
Patricia Rijo;
Conference Paper
Mp. category will be shown later
2020Royleanone Derivatives From Plectranthus spp. as a Novel Class of P-Glycoprotein InhibitorsGarcia, Catarina; Isca, Vera; Pereira, Filipe; Monteiro, Carlos; Ntungwe, Epole; Sousa, Francisco; Dinić, Jelena  ; Holmstedt, Suvi; Roberto, Amílcar; Díaz-Lanza, Ana;
Reis, Catarina; Pešić, Milica  ; Candeias, Nuno; Ferreira, Ricardo; Duarte, Noélia; Afonso, Carlos; Rijo, Patrícia;
Article
21aM21a
2020Validation of long-term 3D glioblastoma cell culture as a novel biomimicking model system for preclinical drug testingStanković, Tijana; Dragoj, Miodrag  ; Stojkovska, J; Dinić, Jelena  ; Podolski-Renić, Ana  ; Obradović, B.; Pešić, Milica  Conference Paper
Mp. category will be shown later
2020Pyrazolo[3,4-d]pyrimidine derivatives, Si306 and pro-Si306, inhibit the growth of sensitive and multidrug resistant glioblastomaDinić, Jelena B.  ; Podolski Renić, Ana M.  ; Marija Nesovic ; Kostić, Ana M.  ; Divac Rankov, Aleksandra  ; Dragoj, Miodrag D.  ; Nikolić, Igor  ; Tasić, Goran  ; Pešić, Milica S.  Conference Paper
Mp. category will be shown later
2020Investigation of inhibitory properties of Michael acceptors on thioredoxin reductase 1 inhibition in vitroJovanović, M.; Podolski Renić, Ana M.  ; Žalubovskis, R.; Pešić, Milica S.  Conference Paper
Mp. category will be shown later
2020Novel TrxR1 Inhibitors Show Potential for Glioma Treatment by Suppressing the Invasion and Sensitizing Glioma Cells to ChemotherapyJovanović, Mirna  ; Dragoj, Miodrag  ; Zhukovsky, Daniil; Dar’in, Dmitry; Krasavin, Mikhail; Pešić, Milica  ; Podolski-Renić, Ana  Article
21M21
2020Further exploration of DVD-445 as a lead thioredoxin reductase (TrxR) inhibitor for cancer therapy: Optimization of potency and evaluation of anticancer potential.Jovanović, Mirna  ; Zhukovsky, Daniil; Podolski-Renić, Ana  ; Žalubovskis, Raivis; Dar'in, Dmitry; Sharoyko, Vladimir; Tennikova, Tatiana; Pešić, Milica  ; Krasavin, MikhailArticle
21aM21a
2020Towards policies that capture the expected value of biomolecular diversity for drug discovery, human health, and well-beingPešić, Milica  ; Egamberdieva, Dilfuza; Kolodziejczyk, Bartlomiej; Elsässer, Simon J.; Neergheen, Vidushi S.; Kagansky, AlexanderArticle
22M22
2020Population pharmacokinetic analysis of bisoprolol in type 2 diabetic patients with hypertensionMomčilović, Stefan ; Jovanović, Andriana; Radojković, Danijela  ; Nikolić, Valentina N.  ; Janković, Slobodan  ; Pešić, Milica  ; Milovanović, Jasmina R.  Article
22M22
2020Protoflavone-Chalcone Hybrids Exhibit Enhanced Antitumor Action through Modulating Redox Balance, Depolarizing the Mitochondrial Membrane, and Inhibiting ATR-Dependent SignalingLatif, Ahmed Dhahir; Jernei, Tamás; Podolski-Renić, Ana  ; Kuo, Ching-Ying; Vágvölgyi, Máté; Girst, Gábor; Zupkó, István; Develi, Sedef; Ulukaya, Engin; Wang, Hui-Chun;
Pešić, Milica  ; Csámpai, Antal; Hunyadi, Attila;
Article
21aM21a
2020A perspective view on the nanomotion detection of living organisms and its featuresVenturelli, Leonardo; Kohler, Anne-Celine; Stupar, Petar; Villalba, Maria, I; Kalauzi, Aleksandar ; Radotić, Ksenija  ; Bertacchi, Massimiliano; Dinarelli, Simone; Girasole, Marco; Pesic, Milica  ;
Banković, Jasna; Vela, Maria E.; Yantorno, Osvaldo; Willaert, Ronnie; Dietler, Giovanni; Longo, Giovanni; Kasas, Sandor;
Article
22M22
2020Novel TrxR1 inhibitors induce oxidative stress and sensitize human multidrug resistant glioblastoma cells to chemotherapyPodolski Renić, Ana M.  ; Jovanović, Mirna  ; Dragoj, Miodrag D.  ; Dinić, Jelena B.  ; Jovanović Stojanov, Sofija  ; Pešić, Milica S.  Conference Paper
Mp. category will be shown later
2020Cytotoxic royleanones from Plectranthus madagascariensis as agents to overcome multidrug resistant in cancerIsca, V.M.S.; Ferreira, R.J.; Santos, D.; Saraiva, L.; Afonso, C.A.M.; Pešić, Milica S.  ; Rijo, P.Conference Paper
Mp. category will be shown later
2019CKT0353, a novel microtubule targeting agent, overcomes paclitaxel induced resistance in cancer cellsDinić, Jelena  ; Ríos-Luci, Carla; Karpaviciene, Ieva; Cikotiene, Inga; Fernandes, Miguel X.; Pešić, Milica  ; Padrón, José M.Article
21M21